Brief: Cipla Announces Launch Of Generic Saxenda For Weight Management Therapy
27/02/2026 17:29
Feb 27 (Reuters) - Cipla Ltd CIPL.NS: CIPLA STRENGTHENS US PORTFOLIO WITH THE LAUNCH OF GENERIC SAXENDA® (LIRAGLUTIDE INJECTION) FOR WEIGHT MANAGEMENT THERAPY CIPLA: TO LAUNCH GENERIC SAXENDA ON AN IMMEDIATE BASIS Source text: ID:nPn2VJ63Sa Further company coverage: CIPL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipla
See all newsIndian pharma stocks up on report US taps drugmakers for critical cancer drug
India's Cipla jumps after Citi sees near-term positive triggers for earnings
Factbox: Global drugmakers invest billions to boost US presence
India raises price cap on cancer drugs to tackle shortage
Brief: Cipla Says USFDA Classified Verna Manufacturing Facility Inspection As Voluntary Action Indicated